Hypertension, Vol 8, 560-565, Copyright © 1986 by American Heart Association
T Okamura, M Miyazaki, T Inagami and N Toda
The possible role of the renin-angiotensin system in the maintenance of
hypertension in two-kidney, one clip hypertensive rats was studied. Plasma
renin activity rose rapidly and markedly in association with the elevation
of blood pressure and then decreased gradually, although blood pressure
remained high. Renin activity in the lung, aorta, and mesenteric artery
also increased with the development of hypertension and then decreased in a
way similar to that of plasma renin activity at the chronic stage of
hypertension. Plasma angiotensin converting enzyme activity did not change
significantly until 16 weeks after unilateral renal artery clipping,
whereas vascular angiotensin converting enzyme activity significantly
increased at the chronic, but not the acute, stage of hypertension. In
chronically renal hypertensive rats, 1- sarcosine, 8-isoleucine angiotensin
II or enalapril, an angiotensin converting enzyme inhibitor, lowered the
blood pressure and enalapril also lowered the angiotensin converting enzyme
activity of vascular tissues. The constrictor effect of angiotensin I was
greater in isolated arteries from chronically hypertensive rats than in
those from age-matched normotensive rats. These results suggest that the
vascular renin-angiotensin system plays an important role in the
maintenance of two-kidney, one clip hypertension. Elevated vascular
angiotensin converting enzyme activity appears to increase local production
of angiotensin II, which results in vasoconstriction by acting directly and
indirectly through adrenergic nerves on vascular smooth muscle.
ARTICLES
Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats
This article has been cited by other articles:
![]() |
S. Heeneman, J. C. Sluimer, and M. J.A.P. Daemen Angiotensin-Converting Enzyme and Vascular Remodeling Circ. Res., August 31, 2007; 101(5): 441 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. J. Farquharson and A. D. Struthers Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure J. Am. Coll. Cardiol., March 6, 2002; 39(5): 767 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lapointe and J.-L. Rouleau Activation of vascular tissue angiotensin-converting enzyme (ACE) in heart failure: Effects of ACE inhibitors J. Am. Coll. Cardiol., March 6, 2002; 39(5): 776 - 779. [Full Text] [PDF] |
||||
![]() |
G. E. Callera, W. A. Varanda, and L. M. Bendhack Ca2+ Influx is Increased in 2-Kidney, 1-Clip Hypertensive Rat Aorta Hypertension, September 1, 2001; 38(3): 592 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kagiyama, A. Varela, M. I. Phillips, and S. M. Galli Antisense Inhibition of Brain Renin-Angiotensin System Decreased Blood Pressure in Chronic 2-Kidney, 1 Clip Hypertensive Rats Hypertension, February 1, 2001; 37(2): 371 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakano, A. Moriguchi, R. Morishita, I. Kida, N. Tomita, K. Matsumoto, T. Nakamura, J. Higaki, and T. Ogihara Role of Angiotensin II in the Regulation of a Novel Vascular Modulator, Hepatocyte Growth Factor (HGF), in Experimental Hypertensive Rats Hypertension, December 1, 1997; 30(6): 1448 - 1454. [Abstract] [Full Text] |
||||
![]() |
D. Henrion, J. Benessiano, and B. I. Levy In Vitro Modulation of a Resistance Artery Diameter by the Tissue Renin-Angiotensin System of a Large Donor Artery Circ. Res., February 1, 1997; 80(2): 189 - 195. [Abstract] [Full Text] |
||||
![]() |
D. N. Muller, J. Bohlender, K. F. Hilgers, D. Dragun, O. Costerousse, J. Menard, and F. C. Luft Vascular Angiotensin-Converting Enzyme Expression Regulates Local Angiotensin II Hypertension, January 1, 1997; 29(1): 98 - 104. [Abstract] [Full Text] |
||||
![]() |
Y. Nakamura, R. Morishita, S. Nakamura, M. Aoki, A. Moriguchi, K. Matsumoto, T. Nakamura, J. Higaki, and T. Ogihara A Vascular Modulator, Hepatocyte Growth Factor, Is Associated With Systolic Pressure Hypertension, September 1, 1996; 28(3): 409 - 413. [Abstract] [Full Text] |
||||
![]() |
H. Shimamoto and Y. Shimamoto Lisinopril Reverses Left Ventricular Hypertrophy Through Improved Aortic Compliance Hypertension, September 1, 1996; 28(3): 457 - 463. [Abstract] [Full Text] |
||||
![]() |
X. C. Li and R. E. Widdop Regional Hemodynamic Effects of the AT1 Receptor Antagonist CV-11974 in Conscious Renal Hypertensive Rats Hypertension, December 1, 1995; 26(6): 989 - 997. [Abstract] [Full Text] |
||||
![]() |
G. Rossi, A. Rossi, A. Sacchetto, E. Pavan, and A. C. Pessina Hypertensive Cerebrovascular Disease and the Renin-Angiotensin System Stroke, September 1, 1995; 26(9): 1700 - 1706. [Abstract] [Full Text] |
||||
![]() |
M.R. Tschudi and T.F. Luscher Age and Hypertension Differently Affect Coronary Contractions to Endothelin-1, Serotonin, and Angiotensins Circulation, May 1, 1995; 91(9): 2415 - 2422. [Abstract] [Full Text] |
||||
![]() |
N. Basso, M. L. Kurnjek, P. Ruiz, and M. A. Cannata Effect of EXP 3174 on Blood Pressure of Normoreninemic Renal Hypertensive Rats Hypertension, February 1, 1995; 25(2): 283 - 287. [Abstract] [Full Text] |
||||
![]() |
M. G. Melaragno and G. D. Fink Enhanced Slow Pressor Effect of Angiotensin II in Two-Kidney, One Clip Rats Hypertension, February 1, 1995; 25(2): 288 - 293. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |